Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

MiMedx makes leadership changes amid accounting probe

Jaclyn Jaeger | July 19, 2018

MiMedx Group, a developer and marketer of regenerative and therapeutic biologics, has appointed Mark Graves as chief compliance officer. The company also is conducting a formal search to fill the newly established positions of chief accounting officer and internal auditor, amid an ongoing investigation into accounting violations.

"We are implementing plans to improve our corporate compliance practices in order to ensure our company adheres to policies with the highest integrity, ethics and legal standards," said David Coles, MiMedx interim chief executive officer.

Graves will be responsible for providing direction and oversight of MiMedx's compliance program, including the company's regulatory and legal compliance matters related to its risk...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.